Abstract
AB027. S027. Factors associated with invasive intraductal papillary mucinous carcinoma
Annals of Pancreatic Cancer
2018;
1:
AB027
(23 April 2018)
Abstract
AB026. S026. What is the optimal surgical strategy for grade-C pancreatic fistula after pancreaticoduodenectomy? A large retrospective multicenter study
Annals of Pancreatic Cancer
2018;
1:
AB026
(23 April 2018)
Abstract
AB025. S025. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB025
(23 April 2018)
Abstract
AB024. S024. Drug responses of patient-derived cell lines in vitro that match drug responses of patient PDAc tumors in situ
Annals of Pancreatic Cancer
2018;
1:
AB024
(23 April 2018)
Abstract
AB023. S023. Identification and targeting of a poor-prognosis subgroup of pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB023
(23 April 2018)
Abstract
AB022. S022. A continuous clonal labeling method to reveal growth dynamics in developing, adult and injured pancreas
Annals of Pancreatic Cancer
2018;
1:
AB022
(23 April 2018)
Abstract
AB021. S021. Expression patterns and clinical implications of immunotherapy targets PD-1, PD-L1 and CD163 in undifferentiated carcinoma of the pancreas with osteoclastlike giant cells
Annals of Pancreatic Cancer
2018;
1:
AB021
(23 April 2018)
Abstract
AB020. S020. Importance of adjuvant hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil with systemic gemcitabine for resectable pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB020
(23 April 2018)
Abstract
AB019. S019. Pancreatectomy plus arterial resection is superior to palliation in patients with locally advanced PDAC
Annals of Pancreatic Cancer
2018;
1:
AB019
(23 April 2018)
Abstract
AB018. S018. The prognostic impact of primary tumor resection in pancreatic neuroendocrine tumors with synchronous multifocal liver metastases
Annals of Pancreatic Cancer
2018;
1:
AB018
(23 April 2018)
Abstract
AB017. S017. Is main pancreatic duct dilation really an independent risk factor for malignancy in main-duct and combined-IPMNs?
Annals of Pancreatic Cancer
2018;
1:
AB017
(23 April 2018)
Abstract
AB016. S016. Lymphadenectomy in resected node-negative pancreatic cancer: are some patients being understaged?
Annals of Pancreatic Cancer
2018;
1:
AB016
(23 April 2018)
Abstract
AB015. S015. Circulating tumor cells dynamics in pancreatic adenocarcinoma correlate with disease status: data from a prospective trial
Annals of Pancreatic Cancer
2018;
1:
AB015
(23 April 2018)
Original Article
Robotic distal pancreatectomy: experience in a high-volume center
Annals of Pancreatic Cancer
2018;
1:
15
(10 April 2018)
Abstract
AB014. S014. Fractional uptake of circulating tumor cells across liver-lung compartments during resections of periampullary cancer aimed at cure
Annals of Pancreatic Cancer
2018;
1:
AB014
(23 April 2018)
Abstract
AB013. S013. Towards early detection of pancreatic cancer: applying NGS in the clinical setup
Annals of Pancreatic Cancer
2018;
1:
AB013
(23 April 2018)
Abstract
AB012. S012. Immunophenotypes of pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2018;
1:
AB012
(23 April 2018)
Abstract
AB011. S011. Mesenchymal pancreatic cancer cells inhibit pancreatic stellate cell activation
Annals of Pancreatic Cancer
2018;
1:
AB011
(23 April 2018)
Abstract
AB010. S010. Pancreatic cystic lesions’ follow-up with abdominal ultrasound scan: could it play an alternative role to the routine use of MRI?
Annals of Pancreatic Cancer
2018;
1:
AB010
(23 April 2018)
Abstract
AB009. S009. Effect of endoscopic iodine 125 seeds brachytherapy on advanced pancreatic cancer: experience of single center
Annals of Pancreatic Cancer
2018;
1:
AB009
(23 April 2018)
Abstract
AB008. S008. Diagnostic yield of intraoperative pancreatoscopy for the investigation of pancreatic IPMN
Annals of Pancreatic Cancer
2018;
1:
AB008
(23 April 2018)
Abstract
AB007. S007. Survival in locally advanced pancreatic cancer: impact of surgical resection after neoadjuvant therapy
Annals of Pancreatic Cancer
2018;
1:
AB007
(23 April 2018)
Abstract
AB006. S006. Variation in longterm oncologic outcomes by types of cancer center accreditation: an analysis of a SEER-Medicare population with pancreatic cancer
Annals of Pancreatic Cancer
2018;
1:
AB006
(23 April 2018)
Abstract
AB005. S005. A multiinstitutional postoperative nomogram for disease recurrence following resection of localized G1/G2 pancreatic neuroendocrine tumors
Annals of Pancreatic Cancer
2018;
1:
AB005
(23 April 2018)
Abstract
AB004. S004. Differences in cancer metabolism between subtypes of pancreatic ductal adenocarcinoma (PDAC) are associated with survival and offer therapeutic opportunities
Annals of Pancreatic Cancer
2018;
1:
AB004
(23 April 2018)